SLBT Stock Forecast: SL Science Holding Ltd. Price Predictions for 2026-2027
Ticker Nerd's systematic factor model, run across ~4,300 US stocks, ranks it 0 of 100 as at 21 Nov 2026 — in the weakest quartile.
One number for the whole business
Consensus tells you what everyone already believes. The model scores SL Science Holding Ltd. on its factor families — the same systematic rank behind the Ticker Nerd portfolio.
Percentile across ~4,300 US stocks on Ticker Nerd’s systematic factor model. Higher is better. How the model is built and tested
Revisions (20): Analysts have, on balance, been raising their forecasts.
Volatility (0): The share price moves around a lot.
Built and run by Aslam Ghouse, an ex-Goldman Sachs systematic trader with 15+ years in markets.
SLBT stock forecast 2026-2027: analyst price targets & predictions
The bullish and bearish analyst opinions on SLBT, reported as data — targets and ratings, the market's view beside the model's.
Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.
Data provided by Twelve Data
Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.
This page is one stock. Monday covers all of them.
SLBT appears in the Radar on the weeks it earns a place.
- Market Radar, every Monday: the week's biggest rank moves across ~4,300 US stocks, and the reason for each.
- The AI build-out map, free: every AI company we track on one page, with the model's Top picks in all four parts.
AI cloud capacity
MSFTAMZNGOOGLORCL
AI chips
NVDAAVGOAMDMU
AI networking and servers
ANETDELLLITECRDO
Data centre power
VRTCEGGEVVST
SLBT vs the S&P 500
Both lines are total return — dividends reinvested — so the comparison is honest on both sides.
Download this chart as an image — free to reuse; link this page as the source.
Data provided by Twelve Data
SLBT analyst estimate revisions
Not the forecast itself — the direction analysts are revising it. Revision direction is one of the model's factor families.
Financials
A margin means little on its own. Each bar marks where the figure sits across the whole US universe we score.
- Trailing P/E
- —
- Price / sales
- 94.3×
- Price / book
- 0.4×
- EV / EBITDA
- —
Cheaper than 3% of US stocks
Cheaper than 88% of US stocks
- Revenue growth (YoY)
- −7.6%
- Earnings growth (YoY)
- —
- Gross margin
- —
- Operating margin
- −70.6%
- Net margin
- −72.5%
Higher than 18% of US stocks
Higher than 16% of US stocks
Higher than 8% of US stocks
- Return on equity
- −167.2%
- Return on assets
- −135.6%
- Dividend yield
- —
Higher than 9% of US stocks
Higher than 2% of US stocks
Bars mark the percentile across the ~4,300 US stocks Ticker Nerd covers, among those reporting the figure.
Key statistics
The headline figures, each with its date. Every row carries its own link — cite it straight from here.
SL Science Holding Ltd. has a market value of $304.3M.
SL Science Holding Ltd. employs 14 people.
Data provided by Twelve Data
SLBT and its peers
The nearest names by industry and size, scored by the same model — like for like.
Take a look at SLBT’s peer groups, ranked by the model: consumer staples stocks · biotech stocks.
Look up any of the roughly 4,300 stocks we score.
The rank is the raw material. Whether the rules would actually own SL Science Holding Ltd. — and when they’d sell — is the membership. See the Ticker Nerd 20 →
Questions about SLBT
How does Ticker Nerd's model rank SLBT?
As at 21 Nov 2026, SL Science Holding Ltd. ranks 0 out of 100 on Ticker Nerd's systematic factor model — a percentile across roughly 4,300 US stocks, built from its factor families. Its strongest factor family is Revisions (20 of 100).
What is the SLBT stock forecast for 2030?
No analyst covering SL Science Holding Ltd. publishes a 2030 price target — Wall Street targets run 12 to 18 months out. Sites quoting a 2030 price for SLBT are extrapolating price history, which says nothing about the business.
What does SL Science Holding Ltd. do?
SL Science Holding Ltd. is a biomedical company focused on cell therapy, exosome products, and cellular and gene therapies. The company develops and commercializes proprietary platforms and related solutions across its main business segments, including Exosome products, CD-19 Armed-T products, and GDT cell therapy products.
About SL Science Holding Ltd.
SL Science Holding Ltd. is a biomedical company focused on cell therapy, exosome products, and cellular and gene therapies. The company develops and commercializes proprietary platforms and related solutions across its main business segments, including Exosome products, CD-19 Armed-T products, and GDT cell therapy products. Its offerings include immune cell development services, skincare product formulations, and milk-derived exosome-based products, reflecting a combination of life sciences and applied biotechnology applications. Based in Taipei, Taiwan, SL Science Holding Ltd. serves the broader healthcare and biotechnology market by advancing technologies used in regenerative medicine, cancer-related research, and specialty bioactive products. The company positions its proprietary GDT platform and related technologies at the center of its current operations, supporting standardized and scalable approaches within the cell therapy field.
CEO Mr. Ching-Dong Wang · 14 employees · Taiwan · https://www.sl-bio.com